Oxidation of 7-dehydrocholesterol and Desmosterol by Human Cytochrome P450 46A1

Overview

Journal J Lipid Res

Publisher Elsevier

Specialty Biochemistry

Date 2014 Jul 15

PMID 25017465

Citations 25

Authors

Sandeep Goyal

Yi Xiao

Ned A Porter

Libin Xu

F Peter Guengerich

Affiliations

Soon will be listed here.

Abstract

Cytochrome P450 (P450 or CYP) 46A1 is expressed in brain and has been characterized by its ability to oxidize cholesterol to 24S-hydroxycholesterol. In addition, the same enzyme is known to further oxidize 24S-hydroxycholesterol to the 24,25- and 24,27-dihydroxy products, as well as to catalyze side-chain oxidations of 7α-hydroxycholesterol and cholestanol. As precursors in the biosynthesis of cholesterol, 7-dehydrocholesterol has not been found to be a substrate of P450 46A1 and desmosterol has not been previously tested. However, 24-hydroxy-7-dehydrocholesterol was recently identified in brain tissues, which prompted us to reexamine this enzyme and its potential substrates. Here we report that P450 46A1 oxidizes 7-dehydrocholesterol to 24-hydroxy-7-dehydrocholesterol and 25-hydroxy-7-dehydrocholesterol, as confirmed by LC-MS and GC-MS. Overall, the catalytic rates of formation increased in the order of 24-hydroxy-7-dehydrocholesterol < 24-hydroxycholesterol < 25-hydroxy-7-dehydrocholesterol from their respective precursors, with a ratio of 1:2.5:5. In the case of desmosterol, epoxidation to 24S,25-epoxycholesterol and 27-hydroxylation was observed, at roughly equal rates. The formation of these oxysterols in the brain may be of relevance in Smith-Lemli-Opitz syndrome, desmosterolosis, and other relevant diseases, as well as in signal transduction by lipids.

Citing Articles

Analytical considerations for accurately capturing the relevant species contributing to vitamin D status in liquid chromatography-tandem mass spectrometry assays.

Volmer D, Stokes C Anal Sci Adv. 2024; 3(1-2):14-20.

PMID: 38716058 PMC: 10989646. DOI: 10.1002/ansa.202100057.

Impact of Oxysterols in Age-Related Disorders and Strategies to Alleviate Adverse Effects.

Ghosh S, Ghzaiel I, Vejux A, Meaney S, Nag S, Lizard G Adv Exp Med Biol. 2023; 1440:163-191.

PMID: 38036880 DOI: 10.1007/978-3-031-43883-7_9.

Chronic Aripiprazole and Trazodone Polypharmacy Effects on Systemic and Brain Cholesterol Biosynthesis.

Korade Z, Anderson A, Balog M, Tallman K, Porter N, Mirnics K Biomolecules. 2023; 13(9).

PMID: 37759721 PMC: 10526910. DOI: 10.3390/biom13091321.

Sterol regulation of developmental and oncogenic Hedgehog signaling.

Daggubati V, Raleigh D, Sever N Biochem Pharmacol. 2021; 196:114647.

PMID: 34111427 PMC: 8648856. DOI: 10.1016/j.bcp.2021.114647.

Medication effects on developmental sterol biosynthesis.

Korade Z, Heffer M, Mirnics K Mol Psychiatry. 2021; 27(1):490-501.

PMID: 33820938 PMC: 8490477. DOI: 10.1038/s41380-021-01074-5.

References

Mast N, Pikuleva I . A simple and rapid method to measure cholesterol binding to P450s and other proteins. J Lipid Res. 2005; 46(7):1561-8. DOI: 10.1194/jlr.D500008-JLR200. View

Muchmore D, McIntosh L, Russell C, Anderson D, Dahlquist F . Expression and nitrogen-15 labeling of proteins for proton and nitrogen-15 nuclear magnetic resonance. Methods Enzymol. 1989; 177:44-73. DOI: 10.1016/0076-6879(89)77005-1. View

Bjorkhem I, Lutjohann D, Diczfalusy U, Stahle L, Ahlborg G, Wahren J . Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. J Lipid Res. 1998; 39(8):1594-600. View

Xu L, Davis T, Porter N . Rate constants for peroxidation of polyunsaturated fatty acids and sterols in solution and in liposomes. J Am Chem Soc. 2009; 131(36):13037-44. PMC: 3656724. DOI: 10.1021/ja9029076. View

de Sain-van der Velden M, Verrips A, Prinsen B, de Barse M, Berger R, Visser G . Elevated cholesterol precursors other than cholestanol can also be a hallmark for CTX. J Inherit Metab Dis. 2008; 31 Suppl 2:S387-93. DOI: 10.1007/s10545-008-0963-1. View

Fumagalli R, Paoletti R . The identification and significance of desmosterol in the developing human and animal brain. Life Sci (1962). 1963; 5:291-5. DOI: 10.1016/0024-3205(63)90159-0. View

Radhakrishnan A, Ikeda Y, Kwon H, Brown M, Goldstein J . Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: oxysterols block transport by binding to Insig. Proc Natl Acad Sci U S A. 2007; 104(16):6511-8. PMC: 1851665. DOI: 10.1073/pnas.0700899104. View

Xu L, Porter N . Reactivities and products of free radical oxidation of cholestadienols. J Am Chem Soc. 2014; 136(14):5443-50. PMC: 4004278. DOI: 10.1021/ja5011674. View

Sandhu P, Baba T, Guengerich F . Expression of modified cytochrome P450 2C10 (2C9) in Escherichia coli, purification, and reconstitution of catalytic activity. Arch Biochem Biophys. 1993; 306(2):443-50. DOI: 10.1006/abbi.1993.1536. View

10.

Shackleton C, Roitman E, Guo L, Wilson W, Porter F . Identification of 7(8) and 8(9) unsaturated adrenal steroid metabolites produced by patients with 7-dehydrosterol-delta7-reductase deficiency (Smith-Lemli-Opitz syndrome). J Steroid Biochem Mol Biol. 2002; 82(2-3):225-32. DOI: 10.1016/s0960-0760(02)00155-3. View

11.

Porter F, Herman G . Malformation syndromes caused by disorders of cholesterol synthesis. J Lipid Res. 2010; 52(1):6-34. PMC: 2999931. DOI: 10.1194/jlr.R009548. View

12.

Korade Z, Xu L, Mirnics K, Porter N . Lipid biomarkers of oxidative stress in a genetic mouse model of Smith-Lemli-Opitz syndrome. J Inherit Metab Dis. 2012; 36(1):113-22. PMC: 3674764. DOI: 10.1007/s10545-012-9504-z. View

13.

Shinkyo R, Xu L, Tallman K, Cheng Q, Porter N, Guengerich F . Conversion of 7-dehydrocholesterol to 7-ketocholesterol is catalyzed by human cytochrome P450 7A1 and occurs by direct oxidation without an epoxide intermediate. J Biol Chem. 2011; 286(38):33021-8. PMC: 3190903. DOI: 10.1074/jbc.M111.282434. View

14.

Janowski B, Willy P, Devi T, Falck J, Mangelsdorf D . An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature. 1996; 383(6602):728-31. DOI: 10.1038/383728a0. View

15.

Marcos J, Guo L, Wilson W, Porter F, Shackleton C . The implications of 7-dehydrosterol-7-reductase deficiency (Smith-Lemli-Opitz syndrome) to neurosteroid production. Steroids. 2004; 69(1):51-60. DOI: 10.1016/j.steroids.2003.09.013. View

16.

Mast N, Charvet C, Pikuleva I, Stout C . Structural basis of drug binding to CYP46A1, an enzyme that controls cholesterol turnover in the brain. J Biol Chem. 2010; 285(41):31783-95. PMC: 2951250. DOI: 10.1074/jbc.M110.143313. View

17.

Theofilopoulos S, Wang Y, Kitambi S, Sacchetti P, Sousa K, Bodin K . Brain endogenous liver X receptor ligands selectively promote midbrain neurogenesis. Nat Chem Biol. 2013; 9(2):126-33. DOI: 10.1038/nchembio.1156. View

18.

Meljon A, Wang Y, Griffiths W . Oxysterols in the brain of the cholesterol 24-hydroxylase knockout mouse. Biochem Biophys Res Commun. 2014; 446(3):768-74. PMC: 4000437. DOI: 10.1016/j.bbrc.2014.01.153. View

19.

Mast N, Li Y, Linger M, Clark M, Wiseman J, Pikuleva I . Pharmacologic stimulation of cytochrome P450 46A1 and cerebral cholesterol turnover in mice. J Biol Chem. 2013; 289(6):3529-38. PMC: 3916554. DOI: 10.1074/jbc.M113.532846. View

20.

Meljon A, Theofilopoulos S, Shackleton C, Watson G, Javitt N, Knolker H . Analysis of bioactive oxysterols in newborn mouse brain by LC/MS. J Lipid Res. 2012; 53(11):2469-83. PMC: 3466016. DOI: 10.1194/jlr.D028233. View